FundedIQ
Health Care

Brightonix Imaging

Brightonix Imaging offers medical imaging AI solutions and SimPET, the most compact and reliable MRI-compatible SiPM PET insert for truly simultaneous PET/MRI studies in small animals, to molecular imaging scientists.

www.brtnx.com Seongdong, South Korea 11-50 employees
Total raised
$5.3M
Rounds
1
Latest
Series C
May 2026

Brightonix Imaging offers medical imaging AI solutions and SimPET, the most compact and reliable MRI-compatible SiPM PET insert for truly simultaneous PET/MRI studies in small animals, to molecular imaging scientists.

Brightonix Imaging has raised $5.3M across 1 round. Its most recent round was a Series C of $5.3M in May 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with FundedIQ

1 round on record.

Date
Round
Amount
Lead investor
May 19, 2026
Series C
$5.3M

Unlock the lead investor and full details for this round.

Start 14-day free trial →

People

Unlock with FundedIQ

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.

Start 14-day free trial →

Brightonix Imaging is featured in

Similar companies

Bunker Kids

Bunker Kids is a startup that provides solutions optimized for achieving personal health goals using data and algorithms.

Series A $10.6M
KaliVir Immunotherapeutics

Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s cutting-edge, next generation oncolytic viral immunotherapy programs combine technologies developed in-house and licensed from University of Pittsburgh’s world-class oncolytic virus and immunotherapy research programs.

Series A $14.0M
Renata Medical

Renata Medical develops purposeful medical devices for unmet pediatric needs.

Series D $25.0M
Happy Health

Happy Health is a mission-driven technology company committed to transforming mental health awareness through the Happy Ring, the first wearable designed to measure your stress and mood 24/7.

Series Unknown $75.0M
Lissun

Lissun is a comprehensive mental health and well-being platform that aims to offer mental health remedies to individuals, corporations, and healthcare facilities. Utilizing advanced technology, it delivers customized wellness programs, therapeutic resources, and psychological assistance to its users.

Series A $5.0M
Leal Therapeutics

Leal Therapeutics creates new treatments for patients.

Series A $30.0M
Teal Health

Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical cancer screenings. We believe that it’s time for women’s health to be designed for women, their preferences, and their experiences. With this in mind, Teal Health is creating the first FDA-approved at-home cervical cancer screening making it simple for a woman to stay current on this life-saving screening from the comfort, convenience, and privacy of her home. Through timely screenings, Teal health plans to eradicate cervical cancer in the US. Teal is backed by passionate and committed investors who share this important vision, including Felicis Ventures, Emerson Collective, Metrodora, and Serena Ventures.

Series A $18.3M
Livingston Hospital and Healthcare Services

Livingston Hospital and Healthcare Services Provide personalized, high-quality healthcare, responsive to the needs of the community.

Private Equity $5.0M
Arab Therapy

Arab Therapy functions as a startup that focuses on mental health.

Seed $2.0M
Notable Systems

Notable Systems offers a health data platform that aims to revolutionize healthcare IT by making health data input and access more user-friendly. Their platform allows for easy data entry, passive data collection, seamless data access across various systems and organizations, and integration of different products via open API. This helps healthcare organizations efficiently capture and access health data.

Series B
Theradaptive

Theradaptive is a clinical-stage biologics company that is privately held and focused on developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology. The company's innovative platform converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers for various medical treatments. Theradaptive's lead candidate, OsteoAdapt SP™, is currently being evaluated in a Phase I/II clinical trial for degenerative disc disease, a condition that causes spinal joint deterioration and pain. This candidate combines Theradaptive's engineered protein AMP2™ with a synthetic bone graft to address this challenging medical issue.

Series Unknown $36.2M
QuantHealth

QuantHealth is an organization that produces software using artificial intelligence technology for drug development data. This software is utilized for conducting patient-focused medication simulations, with the aim of expediting and reducing the risks associated with drug development. By merging data from various sources within clinical and drug development fields, the company's software can forecast how patients will respond to both existing and innovative treatments. This enables pharmaceutical and biotechnology clients to conduct different versions of their clinical trials, enhancing trial design and boosting the chances of successful trials. As a result, QuantHealth aids in uncovering new clinical prospects and optimization strategies.

Series B $45.0M
14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.